Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management

被引:85
作者
Cussons, AJ
Stuckey, BGA [1 ]
Walsh, JP
Burke, V
Norman, RJ
机构
[1] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Keogh Inst Med Res, Nedlands, WA 6009, Australia
[2] Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp Unit, Nedlands, WA 6009, Australia
[3] Queen Elizabeth Hosp, Res Ctr Reprod Hlth, Adelaide, SA, Australia
[4] Univ Adelaide, Dept Obstet & Gynaecol, Adelaide, SA 5001, Australia
关键词
D O I
10.1111/j.1365-2265.2004.02208.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Women with polycystic ovarian syndrome (PCOS) commonly consult endocrinologists or gynaecologists and it is not known whether these specialty groups differ in their approach to management. Objective To compare the investigation, diagnosis and treatment practices of endocrinologists and gynaecologists who treat PCOS. Design and Setting A mailed questionnaire containing a hypothetical patient's case history with varying presentations - oligomenorrhoea, hirsutism, infertility and obesity - was sent to Australian clinical endocrinologists and gynaecologists in teaching hospitals and private practice. Results Evaluable responses were obtained from 138 endocrinologists and 172 gynaecologists. The two specialty groups differed in their choice of essential diagnostic criteria and investigations. Endocrinologists regarded androgenization (81%) and menstrual irregularity (70%) as essential diagnostic criteria, whereas gynaecologists required polycystic ovaries (61%), androgenization (59%), menstrual irregularity (47%) and an elevated LH/FSH ratio (47%) (all P-values < 0.001). In investigation, gynaecologists were more likely to request ovarian ultrasound (91%vs. 44%, P < 0.001) and endocrinologists more likely to measure adrenal androgens (80%vs. 58%, P < 0.001) and lipids (67%vs. 34%, P < 0.001). Gynaecologists were less likely to assess glucose homeostasis but more likely to use a glucose tolerance test to do so. Diet and exercise were chosen by most respondents as first-line treatment for all presentations. However, endocrinologists were more likely to use insulin sensitizers, particularly metformin, for these indications. In particular, for infertility, endocrinologists favoured metformin treatment whereas gynaecologists recommended clomiphene. Conclusions There is a lack of consensus between endocrinologists and gynaecologists in the definition, diagnosis and treatment of PCOS. As a consequence, women may receive a different diagnosis or treatment depending on the type of specialist consulted.
引用
收藏
页码:289 / 295
页数:7
相关论文
共 52 条
[1]   An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries [J].
Amer, SAKS ;
Li, TC ;
Bygrave, C ;
Sprigg, A ;
Saravelos, H ;
Cooke, ID .
HUMAN REPRODUCTION, 2002, 17 (06) :1616-1622
[2]   Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial [J].
Azziz, R ;
Ehrmann, D ;
Legro, RS ;
Whitcomb, RW ;
Hanley, R ;
Fereshetian, AG ;
O'Keefe, M ;
Ghazzi, MN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1626-1632
[3]   Differences between endocrine surgeons and endocrinologists in the management of non-toxic multinodular goitre [J].
Bhagat, MC ;
Dhaliwal, SS ;
Bonnema, SJ ;
Hegedüs, L ;
Walsh, JP .
BRITISH JOURNAL OF SURGERY, 2003, 90 (09) :1103-1112
[4]   Polycystic ovary syndrome (PCOS): Arguably the most common endocrinopathy is associated with significant morbidity in women [J].
Carmina, E ;
Lobo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) :1897-1899
[5]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25
[6]   Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome [J].
Christian, RC ;
Dumesic, DA ;
Behrenbeck, T ;
Oberg, AL ;
Sheedy, PF ;
Fitzpatrick, LA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) :2562-2568
[7]   Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment [J].
Clark, AM ;
Thornley, B ;
Tomlinson, L ;
Galletley, C ;
Norman, RJ .
HUMAN REPRODUCTION, 1998, 13 (06) :1502-1505
[8]   WEIGHT-LOSS RESULTS IN SIGNIFICANT IMPROVEMENT IN PREGNANCY AND OVULATION RATES IN ANOVULATORY OBESE WOMEN [J].
CLARK, AM ;
LEDGER, W ;
GALLETLY, C ;
TOMLINSON, L ;
BLANEY, F ;
WANG, X ;
NORMAN, RJ .
HUMAN REPRODUCTION, 1995, 10 (10) :2705-2712
[9]   A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome [J].
Costello, MF ;
Eden, JA .
FERTILITY AND STERILITY, 2003, 79 (01) :1-13
[10]   EFFECTS OF DIET AND METFORMIN ADMINISTRATION ON SEX HORMONE-BINDING GLOBULIN, ANDROGENS, AND INSULIN IN HIRSUTE AND OBESE WOMEN [J].
CRAVE, JC ;
FIMBEL, S ;
LEJEUNE, H ;
CUGNARDEY, N ;
DECHAUD, H ;
PUGEAT, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) :2057-2062